| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/15/2011 | CA2849668A1 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | CA2811221A1 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | CA2792910A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | CA2792622A1 Methods of predicting and decreasing the risk of pregnancy loss |
| 09/15/2011 | CA2792327A1 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 09/15/2011 | CA2791944A1 Biological products: humanised agonistic anti-pd-1 antibodies |
| 09/15/2011 | CA2791930A1 Pd-1 antibody |
| 09/15/2011 | CA2791863A1 Monoclonal antibodies against c-met |
| 09/15/2011 | CA2790949A1 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | CA2789564A1 Method for purifying immunoglobulin solutions |
| 09/14/2011 | EP2365334A1 Peptide sequence that promotes tumor invasion |
| 09/14/2011 | EP2365331A2 Method to select a single antigen-specfic lymphocyte. |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365062A1 Rapid production of monoclonal antibodies |
| 09/14/2011 | EP2365006A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365005A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2365003A1 CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 09/14/2011 | EP2365002A2 Composition for treating a pathology associated with MSRV/HERV-W |
| 09/14/2011 | EP2365001A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 09/14/2011 | EP2365000A2 Improved nanobodiesTM against tumor necrosis factor-alpha |
| 09/14/2011 | EP2364999A2 Dual-specific ligand and its use |
| 09/14/2011 | EP2364998A1 Antibodies against HMGB1 and fragments thereof |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364996A1 Optimized FC variants and methods for their generation |
| 09/14/2011 | EP2364994A1 Purfied primate CTLA-8 antigens and related reagents |
| 09/14/2011 | EP2364732A1 Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364729A2 IL-17 antagonistic antibodies |
| 09/14/2011 | EP2364728A1 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364726A2 Vaccine against neisseria infection |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364718A1 Enzyme treatment of foodstuffs for celiac sprue |
| 09/14/2011 | EP2364328A2 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis |
| 09/14/2011 | EP2364327A1 Binding members against il-1r1 |
| 09/14/2011 | EP2364326A2 Methods for selecting protease resistant polypeptides |
| 09/14/2011 | EP2364325A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/14/2011 | EP2364162A2 Compositions and methods for diagnosing and treating b-cll |
| 09/14/2011 | EP2301580A9 Container holding anti-VEGF antibodies |
| 09/14/2011 | EP1963366B1 Methods for cyclic nucleotide determination |
| 09/14/2011 | EP1844815B1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers |
| 09/14/2011 | EP1469869B1 Peptide useful in immunomodulation |
| 09/14/2011 | EP1445264B1 Substance specific to pd-1 |
| 09/14/2011 | EP1441766B1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 09/14/2011 | EP1377314B1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/14/2011 | EP1349955B1 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | EP1027440B2 Inhibitor protein of the wnt signal pathway |
| 09/14/2011 | CN1933851B Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 09/14/2011 | CN1891826B Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 09/14/2011 | CN1769295B Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 09/14/2011 | CN1561345B Antibodies to VLA-1 |
| 09/14/2011 | CN102186884A Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 09/14/2011 | CN102186883A Nmda receptor modulators and uses thereof |
| 09/14/2011 | CN102186882A Treatment of thrombocytopenia |
| 09/14/2011 | CN102183653A Cryptosporidium parvum immune colloidal gold detection test paper strip and production method thereof |
| 09/14/2011 | CN102181450A Trichina Ts27 gene, encoding protein and application thereof |
| 09/14/2011 | CN102181402A Monoclonal antibody of high-pathogenicity porcine reproductive and respiratory syndrome (PRRS) virus and preparation method thereof |
| 09/14/2011 | CN102181401A Survivin enzyme-linked immunoassay kit and application thereof |
| 09/14/2011 | CN102181400A Hybridoma cell strain and anti-HCCLM-6 (Human Hepatoma Cell Line) cell secretory protein monoclonal antibody |
| 09/14/2011 | CN102180969A Monoclonal antibody with liver cancer resisting activity and application thereof |
| 09/14/2011 | CN102180968A Anti-schistosoma japonicum Sj14-3-3 protein monoclonal antibody and application thereof in immune diagnosis |
| 09/14/2011 | CN102180967A Method for extracting immunoglobulin A (IgA) of Przewalski's horse noninvasively |
| 09/14/2011 | CN102180965A Carbamazepine immunogen, anti-carbamazepine specific antibody, detection reagent and detection kit |
| 09/14/2011 | CN102180950A Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178952A Method for extracting human TIG (Tetanus Immune Globulin) based on chromatography |
| 09/14/2011 | CN102178951A Method for producing intravenous injection human immune globulin |
| 09/14/2011 | CN101643510B Antibody for recombinant anti CD25 humanized monoclonal antibody |
| 09/14/2011 | CN101580546B Human anti human interferon alpha antibody and application thereof |
| 09/14/2011 | CN101463085B Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 09/14/2011 | CN101270161B Antihuman Reg4 monoclone antibody, preparation, application and hybrid tumor cell strain |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017748 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 09/13/2011 | US8017738 Hemopoietin receptor protein, NR10 |
| 09/13/2011 | US8017737 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 09/13/2011 | US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 09/13/2011 | US8017735 Comprising one or more binding compositions comprising a member selected from a light chain amino acid sequence which comprises CDR-L1 and a heavy chain amino acid sequence which comprises CDR-H1 in association with one or more chemotherapeutic agents; cancer therapy |
| 09/13/2011 | US8017734 Kit for diagnosis of pre-eclampsia |
| 09/13/2011 | US8017729 Nanographite structure/metal nanoparticle composite |
| 09/13/2011 | US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/13/2011 | US8017344 Methods for detecting Th1 cells |
| 09/13/2011 | US8017343 Cytokine zalpha11 ligand antibodies and methods of use |
| 09/13/2011 | US8017133 Multicomponent vaccines |
| 09/13/2011 | US8017130 Method of accelerated vaccination against Ebola viruses |
| 09/13/2011 | US8017121 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 09/13/2011 | US8017118 Anti-hDlk-1 antibody having an antitumor activity in vivo |
| 09/13/2011 | US8017116 Using growth factor specific immunoglobulin as therapeutic in treating eye tissue injury |
| 09/13/2011 | US8017115 Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies |
| 09/13/2011 | US8017114 Human CTLA-4 antibodies and their uses |
| 09/13/2011 | CA2329120C Mara family helix-turn-helix domains and their methods of use |
| 09/13/2011 | CA2329060C Aav5 vector and uses thereof |
| 09/13/2011 | CA2327587C Methods for treatment of haemophilia a patients using human anti-human fviii antibodies |
| 09/13/2011 | CA2224127C Flagellin gene, flac of campylobacter |
| 09/09/2011 | WO2011109338A1 Methods and compositions for treating degos' disease |
| 09/09/2011 | WO2011109308A1 Methods for screening antibodies |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011109280A1 Methods and compositions to treat immune-mediated disorders |